Cargando…

Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome

PURPOSE: The presence of interstitial lung abnormality (ILA) at diagnosis of stage IV non-small cell lung cancer (NSCLC) patients has previously shown to be associated with shorter overall survival (OS). The present study aimed to validate the association between ILA and shorter OS in a larger cohor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Araki, Tetsuro, Dahlberg, Suzanne E., Hida, Tomoyuki, Lydon, Christine A., Rabin, Michael S., Hatabu, Hiroto, Johnson, Bruce E., Nishino, Mizuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444119/ https://www.ncbi.nlm.nih.gov/pubmed/30984804 http://dx.doi.org/10.1016/j.ejro.2019.03.003

Ejemplares similares

M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome
por: Park, Hyesun, et al.
Publicado: (2019)

Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib
por: Nishino, Mizuki, et al.
Publicado: (2020)

Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study
por: Hida, Tomoyuki, et al.
Publicado: (2021)

Interstitial lung abnormalities and physical function
por: Axelsson, Gisli Thor, et al.
Publicado: (2018)

Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP)
por: Hino, Takuya, et al.
Publicado: (2021)

A comparison of visual and quantitative methods to identify interstitial lung abnormalities
por: Kliment, Corrine R., et al.
Publicado: (2015)

Projected lung areas using dynamic X-ray (DXR)
por: Hino, Takuya, et al.
Publicado: (2020)

Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab
por: Nishino, Mizuki, et al.
Publicado: (2012)

Progression of traction bronchiectasis/bronchiolectasis in interstitial lung abnormalities is associated with increased all-cause mortality: Age Gene/Environment Susceptibility-Reykjavik Study
por: Hino, Takuya, et al.
Publicado: (2021)

Spectrum of Pulmonary Fibrosis from Interstitial Lung Abnormality to Usual Interstitial Pneumonia: Importance of Identification and Quantification of Traction Bronchiectasis in Patient Management
por: Hino, Takuya, et al.
Publicado: (2021)

Bronchial epithelial gene expression and interstitial lung abnormalities
por: Menon, Aravind A., et al.
Publicado: (2023)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
por: Yoo, Hongseok, et al.
Publicado: (2020)

Blood gene expression risk profiles and interstitial lung abnormalities: COPDGene and ECLIPSE cohort studies
por: Moll, Matthew, et al.
Publicado: (2022)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
por: Yoo, Hongseok, et al.
Publicado: (2022)

Immune-Related Thyroiditis in Patients with Advanced Lung Cancer Treated with Immune Checkpoint Inhibitors: Imaging Features and Clinical Implications
por: Park, Hyesun, et al.
Publicado: (2023)

The Framingham Heart Study: Populational CT-based phenotyping in the lungs and mediastinum
por: Araki, Tetsuro, et al.
Publicado: (2020)

Low dose chest CT protocol (50 mAs) as a routine protocol for comprehensive assessment of intrathoracic abnormality
por: Kubo, Takeshi, et al.
Publicado: (2016)

Standard-dose vs. low-dose CT protocols in the evaluation of localized lung lesions: Capability for lesion characterization—iLEAD study()
por: Kubo, Takeshi, et al.
Publicado: (2016)

Anterior mediastinal masses in the Framingham Heart Study: Prevalence and CT image characteristics
por: Araki, Tetsuro, et al.
Publicado: (2015)

Simple quantitative chest CT for pulmonary edema
por: Barile, Maria, et al.
Publicado: (2020)

Severe COVID-19 pneumonia leads to post-COVID-19 lung abnormalities on follow-up CT scans()
por: Hino, Takuya, et al.
Publicado: (2023)

Immune-related response assessment during PD-1 inhibitor therapy in advanced non-small-cell lung cancer patients
por: Nishino, Mizuki, et al.
Publicado: (2016)

Interstitial Lung Abnormalities: An Evolving Entity
por: Tomassetti, Sara, et al.
Publicado: (2022)

Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases
por: Wijsenbeek, Marlies S., et al.
Publicado: (2022)

Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
por: Zhou, Qian, et al.
Publicado: (2023)

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer
por: Ricciuti, Biagio, et al.
Publicado: (2019)

Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial
por: Upperton, Sara, et al.
Publicado: (2023)

Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
por: Rose, Jonathan A., et al.
Publicado: (2022)

Interstitial lung abnormalities: Real‐world evidence
por: Rôlo Silvestre, Carina, et al.
Publicado: (2023)

Interstitial lung abnormalities: do symptoms matter?
por: Patel, Avignat S.
Publicado: (2023)

Axillary Lymphadenopathy After Coronavirus Disease 2019 Vaccinations in Patients With Thoracic Malignancy: Incidence, Predisposing Factors, and Imaging Characteristics
por: Nishino, Mizuki, et al.
Publicado: (2022)

Potential Metabolic Biomarkers to Identify Interstitial Lung Abnormalities
por: Tan, Yong, et al.
Publicado: (2016)

Subclinical Interstitial Lung Abnormalities: Lumping and Splitting Revisited
por: Walsh, Simon L. F., et al.
Publicado: (2019)

Increased respiratory morbidity in individuals with interstitial lung abnormalities
por: Hoyer, Nils, et al.
Publicado: (2020)

Interstitial Lung Abnormalities: What Radiologists Should Know
por: Chae, Kum Ju, et al.
Publicado: (2021)

Interstitial lung abnormalities – current knowledge and future directions
por: Axelsson, Gisli Thor, et al.
Publicado: (2021)

Interstitial Lung Abnormalities and Aging Biomarkers: A Mediation
por: Oldham, Justin M.
Publicado: (2021)

Post COVID Interstitial Lung Abnormalities—Incidence and Management
por: Robertshaw, Mark, et al.
Publicado: (2023)

Respiratory muscles in interstitial lung disease: poorly explored and poorly understood
por: Baldi, Bruno Guedes, et al.
Publicado: (2016)

Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new
por: Leone, Paolo Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7pgrvlpdeuk0rt96fceuaa73g1